Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
No Weighted Avg Shares (Diluted) data reported for this period type.
Weighted Avg Shares (Diluted) vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 146.1M | +155.9% | +166.8% | |
| LTM Mar 2026 | 124.17M | +37.8% | +23.4% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | 115.39M | +93.6% | +384.0% |
| LTM Jun 2026 | 67.21M | +5.6% | +9.0% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | 61.01M | +68.6% | +46.8% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | 36.24M | +0.0% | — |
| LTM Mar 2026 | 29.47M | +0.4% | +3.6% | |
| LTM Mar 2026 | 19.58M | +98.7% | +69.8% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
| Peer median (excluding ODTX) | 64.11M | +53.2% | +46.8% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.